Labcorp Holdings Operating Cash Flow decreased by 68.8% to $191.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 935.1%, from $18.50M to $191.50M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a -14.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $487.20M | $767.30M | $697.50M | $356.00M | $572.50M | $373.80M | $653.60M | $121.20M | $351.40M | $275.50M | $579.60M | -$29.80M | $561.10M | $277.30M | $777.20M | $18.50M | $620.60M | $387.20M | $614.20M | $191.50M |
| QoQ Change | — | +57.5% | -9.1% | -49.0% | +60.8% | -34.7% | +74.9% | -81.5% | +189.9% | -21.6% | +110.4% | -105.1% | >999% | -50.6% | +180.3% | -97.6% | >999% | -37.6% | +58.6% | -68.8% |
| YoY Change | — | — | — | — | +17.5% | -51.3% | -6.3% | -66.0% | -38.6% | -26.3% | -11.3% | -124.6% | +59.7% | +0.7% | +34.1% | +162.1% | +10.6% | +39.6% | -21.0% | +935.1% |